Gsk-626616

SynDRA canonical compound SYN2652426 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	DYRK3
Mechanism of action	dual specificity protein kinase inhibitor
Indication	anemia
Disease area	hematology

Cross-references

PubChem CID: 135416229
ChEMBL: CHEMBL5081787

Synonyms

OKY0RM282V
RefChem:782735
GSK626616
UNII-OKY0RM282V
C18H10Cl2N4OS
orb1308256
SCHEMBL2993698
SCHEMBL13041788
SCHEMBL13041807
SCHEMBL29716638
GLXC-15470
EX-A3477
BDBM50613085
GSK 626616 - Bio-X trade mark
AKOS040741813
AC-36386
AS-76659
BG166664
BG300011
DA-53718
HY-105309
CS-0025705
G16346
GSK 626616; GSK-626616
T15422
EN300-22857875
Z3476101065

Look up Gsk-626616 in the interactive SynDRA portal →